Ultragenyx Pharmaceutical, Inc., a biotech firm specializing in treatments for rare and ultra-rare diseases, has emerged as a compelling investment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE